Adient price target raised to $27 from $25 at Barclays

Barclays raised the firm’s price target on Adient (ADNT) to $27 from $25 and keeps an Equal Weight rating on the shares following the fiscal Q1 report. The firm says an attractive opportunity is emerging for the company in 2027 and 2028.